Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

201685 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Leukemia

Volume 30, Issue 12, pp. 2342-2350

Field-Weighted Citation Impact: 4.20